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Abstract
Host cell invasion and dissemination within the host are hallmarks of virulence for many pathogenic microorganisms. As
concerns Trypanosoma cruzi, which causes Chagas disease, the insect vector-derived metacyclic trypomastigotes (MT)
initiate infection by invading host cells, and later blood trypomastigotes disseminate to diverse organs and tissues. Studies
with MT generated in vitro and tissue culture-derived trypomastigotes (TCT), as counterparts of insect-borne and
bloodstream parasites, have implicated members of the gp85/trans-sialidase superfamily, MT gp82 and TCT Tc85-11, in cell
invasion and interaction with host factors. Here we analyzed the gp82 structure/function characteristics and compared
them with those previously reported for Tc85-11. One of the gp82 sequences identified as a cell binding site consisted of an
a-helix, which connects the N-terminal b-propeller domain to the C-terminal b-sandwich domain where the second binding
site is nested. In the gp82 structure model, both sites were exposed at the surface. Unlike gp82, the Tc85-11 cell adhesion
sites are located in the N-terminal b-propeller region. The gp82 sequence corresponding to the epitope for a monoclonal
antibody that inhibits MT entry into target cells was exposed on the surface, upstream and contiguous to the a-helix.
Located downstream and close to the a-helix was the gp82 gastric mucin binding site, which plays a central role in oral T.
cruzi infection. The sequences equivalent to Tc85-11 laminin-binding sites, which have been associated with the parasite
ability to overcome extracellular matrices and basal laminae, was poorly conserved in gp82, compatible with its reduced
capacity to bind laminin. Our study indicates that gp82 is structurally suited for MT to initiate infection by the oral route,
whereas Tc85-11, with its affinity for laminin, would facilitate the parasite dissemination through diverse organs and tissues.
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Introduction
Host cell invasion and dissemination within the host are
required for many pathogenic microorganisms to establish
infection. Different pathogens may employ common tactics as
well particular strategies for interaction with host components and
for cell invasion. Enteropathogenic bacteria rely on their ability to
bind to mucins, the main component of the mucus layer that
protects the gastrointestinal mucosa, in order to reach the target
cells. Shigella dysenteriae, for instance, adheres preferentially to
colonic mucin as the first step to gain access to the colonic
epithelial cells, within which it replicates after invasion [1,2].
Helicobacter pylori, which does not invade cells but attaches to gastric
epithelial cells and causes ulcers, binds to human gastric mucin at
acidic pH [3]. Trypanosoma cruzi, the protozoan parasite that causes
Chagas disease, binds selectively to gastric mucin as a prelude to
traverse the mucus layer towards the underlying target cells [4].
Microbial infection may be facilitated by binding to extracellular
matrix components. An invasive Escherichia coli isolate was found to
bind basement-membrane laminin as opposed to non-invasive E.
coli that exhibited only low-level laminin binding [5]. Infection by
T. cruzi was dramatically reduced by stable knock down of host cell
laminin gamma-1 by RNA interference [6].
Studies with MT generated in vitro and tissue culture-derived
trypomastigotes (TCT), as counterparts of insect-borne and
bloodstream parasites, have revealed the MT stage-specific surface
molecule gp82 and Tc85-11 expressed in TCT, which are
members of the gp85/trans-sialidase superfamily, as key players
in the process of cell invasion [7,8]. Gp82 mediates MT invasion
of host cells by inducing signaling cascades that culminate in
lysosome exocytosis [9], an event required for parasite internal-
ization [10,11]. In vivo, gp82 plays a central role in the
establishment of T. cruzi infection in mice by the oral route [12],
a mode of transmission that has been responsible for frequent
outbreaks of acute Chagas disease in recent years [13–19]. A
property of gp82 critical for oral T. cruzi infection is its ability to
bind to gastric mucin present in the mucus layer that protects the
stomach mucosa [4]. It has been proposed that, upon binding to
gastric mucin, MT migrate through the mucus layer and reach the
underlying epithelial cells that they invade in a gp82-mediated
manner [20–22]. In vitro, MT were found to efficiently translocate
through a gastric mucin layer [23]. Whether TCT exhibit such an
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ability has yet to be examined. On the other hand, TCT express
Tc85-11 that binds laminin, a property that may enable the
parasite to traverse extracellular matrices and reach the target cells
[24].
Here we analyzed the structural characteristics of MT gp82 and
their relation with specific functions of gp82 in host cell invasion
and in gastric mucin binding. In addition, the structural/
functional properties of MT gp82 were compared to those
reported for TCT Tc85-11.
Methods
Homology Modeling of gp82 Protein
For the modeling of gp82 protein, we selected as a template the
high resolution crystal structure of inhibitor-bound Trypanosoma
rangeli sialidase (PDB 1N1T), which is closely related T. cruzi trans-
sialidase, [25]. The gp82 sequence (Genbank L14824), which
exhibited.39% identity when aligned with T. rangeli sialidase, was
modeled using YASARA software (www.yasara.org) based on T.
rangeli sialidase structure obtained from the Protein Data Base
(www.rcsb.org). The best model was prepared for energy
minimization and all the hydrogen atoms and other missing
atoms from the model were created. Parameters for the force field
were obtained from YAMBER3 [26], the pKa values for Asp, Glu,
His and Lys residues were predicted. Based on the pH 7.0, the
protonation states were assigned according to convention: Asp and
Glu were protonated if the predicted pKa was higher than the pH,
His was protonated if the predicted pKa was higher than the pH
and it did not accept a hydrogen bond, otherwise it was
deprotonated, Cys was protonated, Lys was deprotonated if the
predicted pKa was lower than the pH, Tyr and Arg were not
modified (www.yasara.org). A simulation box was defined at 15 A˚
around all atoms of each macromolecular complexes, then it was
filled with water molecules and Na/Cl counter ions, that were
placed at the locations of the lowest/highest electrostatic potential,
until the cell neutralization, and the requested NaCl concentration
reached 0.9%. A short molecular dynamics (MD) simulation was
performed for the solvent adjust, and water molecules were
subsequently deleted until the water density reached 0.997 g/ml.
A short steepest descent energy minimization was carried out until
the maximum atom speed dropped below 2,200 m/s. Then 500
steps of simulated annealing were performed with a temperature
0 K. Finally, a 45 nanosecond simulation at 298 K and a non-
bonded cutoff of 7.86 A was carried out. A snapshot was saved
every 7.5 picosecond. The graphical analysis was carried out using
Visual Molecular Dynamics (VMD) software [27]. The average
structure based on the last 20 nanoseconds was submitted to an
energy minimization and used in all analyses. Validation
procedure using the program PROCHECK [28] demonstrated
that the final 3D structure agreed with the distance restrains and
offered good geometry and side chain packing. The residues’
exposure for the solvent was analyzed using the program DSSP
[29].
Production and Purification of Recombinant Protein J18
The recombinant protein J18, containing the full-length T. cruzi
gp82 (GenBank L14824) in frame with gluthatione S-transferase
(GST), was produced in E. coli DH5-a and purified as previously
described [30].
Binding of the Recombinant Protein J18 to Gastric Mucin
or Laminin
Microtiter plates (96 wells) were coated with mucin from
porcine stomach (Type III, Sigma) or with laminin in PBS (10 mg/
well). The antibodies used to ascertain by ELISA the effective
coating were: antibodies against gastric mucin, generated by
immunizing mice with porcine gastric mucin as described [4], and
rabbit antibodies to mouse laminin, kindly provided by Dr. Jose´
Daniel Lopez, Universidade Federal de Sa˜o Paulo. For J18
binding assay, the microtiter plates coated with gastric mucin or
laminin were blocked with PBS containing 2 mg/ml bovine serum
albumin (PBS/BSA) for 1 h. The plates were sequentially
incubated at 37uC for 1 h with the recombinant protein J18,
and peroxidase-conjugated anti-mouse IgG, all diluted in PBS/
BSA, and the final reaction was revealed by o-phenilenediamine
and the absorbance at 490 nm was read in ELx800TM absorbance
microplate reader (BioTek).
Parasites
T. cruzi (Y strain) was maintained cyclically in mice and in liver
infusion tryptose (LIT) medium containing 5% fetal bovine serum.
To promote differentiation to metacyclic forms, the parasites were
grown for one passage in Grace’s medium (Invitrogen). For MT
purification, parasites harvested from cultures at the stationary
growth phase were passed through DEAE-cellulose column, as
described [31]. TCT were obtained as follows: Vero cells,
purchased from Instituto Adolfo Lutz, Sa˜o Paulo, Brazil, were
infected with MT. Five to six days later, the trypomastigotes
released into the medium were collected.
Parasite Migration Assay through Gastric Mucin Layer
Polycarbonate transwell filters (3 mm pores, 6.5 mm diameter,
Costar) were coated with 50 ml of a preparation containing
10 mg/ml gastric mucin in water. Parasites (MT or TCT)
suspended in 600 ml PBS were added to the bottom of 24-well
plates (1.06107 parasites/well). Mucin-coated transwell filters
were placed onto parasite-containing wells, and 100 ml PBS were
added to the filter chamber. At 30 and 60 min incubation at 37uC,
10 ml were collected from the filter chamber for determination of
parasite number. Assays were also performed with transwell filters
coated with 50 ml of a preparation containing gastric mucin
(10 mg/ml) mixed with the recombinant protein J18 (1 mg/ml) or
GST (1 mg/ml), or coated with 50 ml of a gastric mucin
preparation (10 mg/ml) mixed with the 20-mer synthetic peptide
p7 or p7* at. 1 mg/ml.
Treatment of Parasites with Pepsin
Treatment of parasites with pepsin was performed under two
conditions, one using sodium citrate 0.1 mM, pH 3.5, and the
other using the same buffer plus 0.9% NaCl, at pH 3.5. Parasites
were incubated with pepsin at 2 mg/ml in either of the citrate
buffer, at 37uC for 30 min, and then examined in the light
microscope.
Statistical Analysis
The significance level of experimental data was calculated using
the Student’s t test, as implemented in the program GraphPad
InStat.
Ethics Statement
All procedures and experiments conformed with the regula-
tion of the Universidade Federal de Sa˜o Paulo Ethical
Committee, in accord with Resolution Nu 196 (10/10/1996)
of National Council of Health, and the study was approved by
the Committee.
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Figure 1. Sequences of T. cruzi surface proteins gp82 and Tc85-11. Shown are the aminoacid sequences deduced from cDNA clone J18,
containing the full-length metacyclic stage gp82 (GenBank L14824), and from the cDNA insert containing Tc85-11 open reading frame (GenBank
AF085686). In gp82, the sequences identified as P4 and P8 represent the host cell binding sites, P3 corresponds to the epitope for mAb 3F6, and P7
constitutes the main gastric mucin-binding site. In Tc85-11, the sequences corresponding to cell adhesion sites are identified as N-17, N-20 and N-21
and overlap with laminin-binding sites N17 and N-21 [34]. Points represent residues that are conserved in the two proteins, nonconserved amino
acids are indicated, and dashes represent residues that are lacking.
doi:10.1371/journal.pone.0042153.g001
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Figure 2. Comparison of gp82 sequences associated with recognition by mAb 3F6 or binding to gastric mucin with the equivalent
sequences in Tc85-11. A) The gp82 sequence identified as the epitope for mAb 3F6 (P3) was aligned with the equivalent Tc85-11 sequence, with
the differences highlighted in red. B) Soluble extracts of MT and TCT were analyzed by Western blot using mAb 3F6. C) The gp82 sequence
corresponding to the gastric mucin-binding site (P7) was aligned with the equivalent Tc85-11 sequence, with the changed residues indicated in red.
D) Transwell filters coated with gastric mucin were placed onto 24-well plates containing MT or TCT. After 30 or 60 min incubation, samples from the
filter chamber were collected and the number of parasites counted. Values are the means 6 SD of three independent experiments. E) Assays were
performed as in (D) using transwell filters coated with gastric mucin alone, or mixed with the recombinant protein J18 or GST. The difference
between the filter containing J18 and the control was significant (*P,0.05, **P,0.01). F) Assays were performed as in (D) using transwell filters
coated with gastric mucin alone, or mixed with the synthetic peptide P7 or P7*. The difference between the filter containing P7 and the control was
significant (*P,0.05, **P,0.0005).
doi:10.1371/journal.pone.0042153.g002
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Results
Comparative Analysis of Sequences Relevant for T. Cruzi
Infection in gp82 and Tc85-11 Proteins
In previous studies, the amino acid sequences deduced from a
cDNA clone (J18) containing the full-length metacyclic stage gp82
(GenBank L14824) [32] and of a cDNA insert containing Tc85-11
open reading frame (GenBank AF085686) [24] have been
reported. Here we compared the two sequences (Fig. 1), which
share 54% identity and 64% similarity, focusing on sites
considered to be important for T. cruzi infection. In gp82, the
sequences P4 (amino acids 254–273) and P8 (amino acids 294–
313) identified as the host cell adhesion sites [33] are localized in
the C-terminal domain (Fig. 1). By contrast, the functionally
equivalent sites in Tc85-11, represented by sequences N-17, N-20
and N-21 (Fig. 1), are present in the N-terminal domain [34]. The
gp82 sequence P3 (amino acids 244–263), corresponding to the
epitope for monoclonal antibody (mAb) 3F6 [33], which inhibits
MT entry into host cells [35], partially overlaps the P4 sequence
(Fig. 1). Compared to P3, the equivalent sequence in Tc85-11
exhibited considerable difference, with several non conservative
amino acid substitutions (Fig. 2A) that may preclude its
recognition by the referred antibody. No protein was revealed
by mAb 3F6 in Western blot of TCT extract (Fig. 2B). P7 (amino
acids 284–303), the sequence identified as the main gp82 gastric
mucin-binding site that is associated with the MT capacity to
migrate through the gastric mucin layer [4], had its counterpart in
Tc85-11 and exhibited five amino acid substitutions, two of which
were conservative (Fig. 2C). Assays were performed in which the
ability of MT and TCT to traverse a gastric mucin layer was
compared. The number of MT that traversed the mucin layer was
about two-fold higher than TCT (Fig. 2D). Translocation of non
infective epimastigotes, which do not express gp82 or Tc85-11,
was about 25-fold lower as compared to MT. To further
demonstrate that the ability of metacyclic forms to migrate
through the gastric mucin layer was dependent on gp82, more
specifically on P7 sequence, additional experiments were carried
out. In one set, the transwell filters were coated with gastric mucin
mixed with the recombinant protein J18, which is fused to GST,
or with gastric mucin mixed with GST. Migration of metacyclic
forms through the gastric mucin mixed with J18 was significantly
reduced, whereas the presence of GST had no inihibitory effect
(Fig. 2E). The other experiment consisted in coating the transwell
filters with gastric mucin mixed with the synthetic peptide P7 or
P7*. Peptide P7 corresponds to the gp82 gastric mucin binding site
and was shown to inhibit the parasitism of gastric mucosal
epithelium in oral T. cruzi infection [4]. Peptide P7* (LA-
DLAGWLSPSDVGGAINST) has the same composition as P7
Figure 3. Comparative analysis of Tc85-11 sequences mapped as laminin-binding sites and the equivalent sequences in gp82. A)
The Tc85-11 sequences N-17 and N-21, corresponding to laminin-binding sites, were aligned with the equivalent sequences in gp82, with the
differences highlighted in red. B) Microtiter plates were coated with laminin or gastric mucin (10 mg/well), and ELISA assay was performed using anti-
laminin or anti-gastric mucin antisera, at the indicated dilutions. C) Laminin- or gastric mucin-coated plates were incubated with J18, the recombinant
protein containing the full length gp82 sequence, at the indicated concentrations. Binding of J18 was revealed by anti-J18 antibodies. Values are the
means 6 SD of triplicates of a representative experiment.
doi:10.1371/journal.pone.0042153.g003
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but with a scrambled sequence and is devoid of inhibitory effect on
oral infection by metacyclic forms [4]. As shown in Fig. 2F, the
presence of P7, but not of P7*, profoundly affected the parasite
traversal through the gastric mucin.
Tc85-11 is a laminin-binding protein [24]. Laminin-binding
sites of Tc85-11have been mapped to sequences N-17 and N-21
(Fig. 1) that are nested within the target cell adhesion domain [34].
Equivalent sequences in gp82 exhibited marked differences, such
as gaps either in J18 or Tc85-11, in addition to non-conservative
amino acid substitutions (Fig. 3A), which may interfere with
laminin-binding capacity. Assays to address this question were
performed using microtiter plates coated with laminin, or gastric
mucin as control. First, the effective coating of plates with these
compounds was ascertained using antibodies to laminin or gastric
mucin. The reactivity of serum containing anti-laminin and anti-
gastric mucin antibodies with laminin and gastric mucin decreased
with the increasing serum dilution (Fig. 3B), what assured us that
we could use these coated plates to compare the J18 binding
capacity. Next, the recombinant protein J18 containing the full-
length gp82 sequence, at varying concentrations, was added to
plates coated with laminin or gastric mucin, and the binding was
revealed with anti-J18 antibodies. The ability of J18 to bind
laminin was lower than its capacity to bind gastric mucin (Fig. 3C).
Modeling of Metacyclic Form gp82 Protein
To obtain the structure model of MT gp82, we employed
homology modeling, the same technique reported for obtaining
the three-dimensional structure of Tc85-11. By using as templates
the crystal structure of T. cruzi trans-sialidase and T. rangeli
sialidase, which are closely related [25,36], Tc85-11 was found to
consist of a b-propeller domain at the N-terminal region
connected by an a-helix joint to a b-sandwich domain at the C-
terminal region [34]. Here, the high resolution crystal structure of
inhibitor-bound T. rangeli sialidase (PDB 1N1T) was used as
template. The model of gp82 was submitted to a molecular
dynamics, and after 15 ns was stable (Fig. S1). The average model
was analyzed with PROCHECK and all the stereochemical
parameters were inside or better than those provided. In that
model, the host cell binding site P4 was found to be part of the a-
helix whereas P8 was located in the b-sandwich domain (Fig. 4A).
Both P4 and P8 were exposed at the gp82 surface (Fig. 4B),
compatible with the ability of these sequences to interact with host
cells [33]. In P4, five amino acids with charged polar side chains
had high solvent accessibility, whereas in P8 three amino acids
were highly solvent-accessible (Table 1). Along the P3 sequence
that corresponds to the epitope for mAb 3F6, nine residues
displayed high solvent accessibility (Table 2). The almost full
exposure of P3 (Fig. 4C) is in accord with the intense reaction of
mAb 3F6 with live MT surface (Fig. S2). By binding to P3, which
partially overlaps with the cell binding site P4 (Fig. 1 and 4D),
mAb 3F6 possibly impairs parasite adhesion/invasion. Compared
to the cell binding sites, the gastric mucin binding site represented
by sequence P7 contained fewer solvent-accessible amino acids
(Table 2) and was less exposed at gp82 surface (Fig. 5A). More
specifically, its C-terminal portion that overlaps with the N-
terminal sequence of P8 was exposed, whereas the more
Figure 4. The structural model of gp82. A) Cartoon representation highlighting the cell binding sites P4 (magenta) and P8 (blue). B) Surface
representation of sites P4 and P8. C) The epitope for mAb 3F6 (P3) is highlighted (green). D) The portion of P3 that overlaps with P4 is indicated
(yellow).
doi:10.1371/journal.pone.0042153.g004
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hydrophobic portion was buried (Fig. 5B). The surface represen-
tation of P7 in relation to the cell binding site P4, shown in Fig. 5C,
suggests the possibility of simultaneous binding of gp82 to gastric
mucin and the host cell, through P7 and P4, respectively. As
concerns the VTV motif (VTVxNVxLYNR), highly conserved in
gp85/trans-sialidase superfamily [37], it contained many amino
acids barely accessible to solvent and, accordingly, was mostly
buried (Fig. S3).
Differential Susceptibility of MT and TCT to Pepsin
Digestion
MT gp82 resists degradation by pepsin at acidic pH in vitro
[20] and is preserved upon contact with the gastric juice in oral
infection. In addition, MT surface is covered with protease-
resistant mucin-like molecules [38], which protect the parasites
from lysis in the gastric milieu. As blood trypomastigotes have
been reported to rarely infect mice by the oral route [39], we
checked whether these parasite forms are susceptible to peptic
digestion, using TCT. When treated with pepsin at pH 3.5 for
30 min, TCT was mostly lysed (.90%) whereas MT preserved
their morphology and motility.
Discussion
The metacyclic stage surface molecule gp82, which is highly
conserved among genetically divergent T. cruzi lineages [40], plays
a central role in the process of host cell invasion and in the
establishment of infection by the oral route, through its cell
adhesion and gastric mucin-binding properties [4,7]. In this study,
we have shown that the referred properties conform to the
structural features of gp82. Both P4 and P8 sequences, identified as
the host cell binding sites of gp82, were exposed. This should
enable their recognition by the corresponding receptors. Of the
two sites, P4 has been shown in diverse experiments to be the main
cell binding site [33,41]. As regards P3, the epitope for the
monoclonal antibody 3F6, its partial overlap with P4 and the
confirmation that it is exposed on the surface reinforced the notion
that this antibody exerts its inhibitory effect on MT internalization
by sterical hindrance of P4. The gp82 sequence P7, identified as
the gastric mucin-binding site, was nested in the cell-binding
domain. Whether this positioning is favorable to gp82 interaction
with gastric mucin and subsequently with the target epithelial cells,
is not known. We visualize one possible scenario. In oral infection,
metacyclic forms bind to gastric mucin upon reaching the stomach
and migrate toward the underlying gastric epithelial cells. The
recognition of the gp82 sequence P4 by its target cell receptor
would facilitate the P7 release from the gastric mucin, enabling the
parasites to initiate cell invasion. As the proximity of P4 to P7 is
not so close, this would allow the P4-mediated binding of gp82 to
target cells, while still bound to gastric mucin. In this scenario, P8
would play a minor role because of its partial overlap with P7.
Distinct from MT, blood trypomastigotes are inefficient in
infecting mice by the oral route [39]. This could be due to the
differential capacity of the two infective forms in migrating
through the gastric mucin layer. When that possibility was tested
using TCT, it was found that this parasite form traversed the
mucin layer at two-fold lower numbers than MT, a result
compatible with the observation that, as compared to the gp82
sequence P7, the equivalent sequence in Tc85-11 protein
displayed a few non-conservative amino acid substitutions.
Table 1. The solvent accessibility of the residues from
peptides P4 and P8, measured in water exposed surface in A˚2.
P4 P8
Residue
Amino
Acid
Solvent
Accessibility Residue
Amino
Acid
Solvent
Accessibility
254 L 67 294 N 66
255 A 32 295 S 57
256 R 129 296 A 15
257 L 9 297 S 47
258 T 67 298 G 56
259 E 111 299 D 95
260 E 54 300 A 18
261 L 7 301 W 4
262 K 122 302 I 39
263 T 64 303 D 0
264 I 0 304 D 47
265 K 82 305 Y 3
266 S 64 306 R 107
267 V 31 307 S 24
268 L 0 308 V 2
269 S 37 309 N 70
270 T 67 310 A 2
271 W 9 311 K 111
272 S 40 312 V 8
273 K 157 313 M 56
doi:10.1371/journal.pone.0042153.t001
Table 2. The solvent accessibility of the residues from
peptides P3 and P7, measured in water exposed surface in A˚2.
P3 P7
Residue
Amino
Acid
Solvent
Accessibility Residue
Amino
Acid
Solvent
Accessibility
244 R 91 284 P 18
245 A 71 285 T 29
246 N 111 286 A 64
247 D 140 287 G 13
248 K 177 288 L 0
249 G 13 289 V 9
250 S 91 290 G 1
251 V 86 291 L 18
252 I 87 292 L 14
253 S 48 293 S 19
254 L 67 294 N 66
255 A 32 295 S 57
256 R 129 296 A 15
257 L 9 297 S 47
258 T 67 298 G 56
259 E 111 299 D 95
260 E 54 300 A 18
261 L 7 301 W 4
262 K 122 302 I 39
263 T 64 303 D 0
doi:10.1371/journal.pone.0042153.t002
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Expression of gp82 or Tc85-11 on the parasite surface is
presumably an important requirement for gastric mucin translo-
cation. Epimastigotes that lack either of these molecules displayed
very reduced ability to migrate through a gastric mucin layer,
about 25 fold lower than MT. The difference between MT and
TCT in traversing the gastric mucin layer did not seem to be
sufficient to explain the low efficiency of blood trypomastigotes in
infecting by the oral route. The possibility that blood trypomas-
tigotes were more susceptible to pepsin digestion at acidic pH was
tested using TCT. Lysis of TCT by pepsin at acidic pH was higher
than 90% whereas MT preserved their morphology and motility,
in the same manner as MT recovered from the mouse stomach
1 hour after oral infection [21]. If the blood trypomastigotes
resisted peptic digestion, it is possible that they would be able to
overcome the gastric mucin barrier.
Metacyclic forms interact with host cells and host components
at the portal of entry, in the skin, the ocular mucosa or the
stomach, whereas blood trypomastigotes have to overcome many
barriers such as extracellular matrices and basal laminae to reach
the target cells. In this context, the interaction of parasites with
these components is critical for the dissemination within the host,
and such a requirement is possibly fulfilled by the expression of
Tc85-11, with its laminin-binding property [24], and/or by an
85 kDa protein that interacts with cells bearing fibronectin
molecules [42]. It is of interest that the Tc85-11 sequences mapped
as laminin-binding sites were nested in the cell adhesion domain
[34]. Away from the laminin-binding sites of Tc85-11, in the C-
terminal portion, lied the conserved VTV motif, whose function is
not known. By using a synthetic peptide based in VTV motif, it was
shown that it binds to cytokeratin 18 [43]. But this finding probably
does not bear any association with the recognition of Tc85-11 by
cytokeratin 18 and TCT entry into host cells. Transient silencing of
cyotkeratin 18 gene in RNAi-treated HeLa cells did not affect
binding and invasion of TCT [44]. Furthermore, a recombinant
protein based on amastigote surface protein-2 containing the VTV
motif failed to bind cytokeratin 18 [44]. In gp82, the VTV motif
localized very close to the hydrophobic sequence that putatively is
replaced by GPI, at the C-terminal end. This localization, and the
fact that VTV motif is mostly unexposed, makes its interaction with
host cell or with host factors unlikely.
In summary, metacyclic forms and blood trypomastigotes appear to
use very closely related surface molecules to interact with distinct host
components that they would find in natural infection, in order to reach
the target cells and to ascertain their survival within the host.
Figure 5. Surface representation of gp82 showing the gastric mucin-binding site. A) P7, the gastric mucin-binding site is highlighted in
orange. B) Shown is the site P7 (orange) overlapped (yellow) with the cell binding site P8 (blue). C) The relative localization of P7 (orange) and the cell
binding site P4 (magenta).
doi:10.1371/journal.pone.0042153.g005
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Supporting Information
Figure S1 The a-carbon Root Mean Square Deviation
from the gp82 model plotted as a function of simulation
time. A small oscillation was observed during the first 15 ns and
after that the model became stable.
(TIF)
Figure S2 Reaction of T. cruzi metacyclic trypomasti-
gotes with mAb 3F6. Live parasites were incubated with mAb
3F6 and processed for visualization at fluorescence microscope.
(TIF)
Figure S3 The MT gp82 VTV motif. A) VTV motifs of gp82
and Tc85-11 are aligned. B) Surface representation of gp82 VTV
motif.
(TIF)
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